Microbiome, Potential Therapeutic Agents: New Players of Obesity Treatment
Journal of Microbiology and Biotechnology · 2025
DOI: 10.4014/jmb.2501.01024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Microbiology and Biotechnology, 2025. Verfasst von Maqsood Ali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, College of Medicine, Soonchunhyang University, Cheonan 31151, Republic of Korea. Hauptthemen laut MEDLINE: Obesity, Gastrointestinal Microbiome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Korea Environmental Industry and Technology Institute, Ministry of Environment, Soonchunhyang University.
Abstract (Originalsprache)
Obesity is a global pandemic, and recent research has established a correlation between the microbiome and obesity, indicating potential treatment possibilities. This review evaluated the potential of the microbiome in treating obesity by targeting anti-adipogenesis and adipose tissue browning mechanisms. The microbiome impacts adipogenesis through lipogenesis and inflammation pathways and influences adipose tissue browning via the secretion of gut hormones and short-chain fatty acids. Understanding these mechanisms could pave the way for interventions targeting the gut microbiome to reduce obesity-related adiposity. While our understanding of the specific microbial species, metabolites, and signaling pathways involved in these processes is still limited, this review highlights the potential of microbiome-based therapies for obesity. Further research focused on identifying key microbial players and their mechanisms of action will be crucial for developing targeted and effective interventions. This will ultimately contribute to a more comprehensive understanding of obesity pathogenesis and facilitate the development of novel therapeutic strategies to combat this global health crisis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, College of Medicine, Soonchunhyang University, Cheonan 31151, Republic of Korea.
- Saelounbio, Seoul, Republic of Korea.
- Nakdonggang National Institute of Biological Resources, Sangju 37242, Republic of Korea.
Förderung
- Korea Environmental Industry and Technology Institute
- Ministry of Environment
- Soonchunhyang University
Zitieren
APA
Ali, M., Iqbal, N., Rakib, M. A., Lee, K. A., Lee, M. H., & Kim, Y. S. (2025). Microbiome, Potential Therapeutic Agents: New Players of Obesity Treatment. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2501.01024
Vancouver
Ali M, Iqbal N, Rakib MA, Lee KA, Lee MH, Kim YS. Microbiome, Potential Therapeutic Agents: New Players of Obesity Treatment. Journal of Microbiology and Biotechnology. 2025. doi:10.4014/jmb.2501.01024
BibTeX
@article{Ali2025,
author = {Ali, Maqsood and Iqbal, Navid and Rakib, Md Abdur and Lee, Kyung-Ah and Lee, Mi-Hwa and Kim, Yong-Sik},
title = {Microbiome, Potential Therapeutic Agents: New Players of Obesity Treatment},
journal = {Journal of Microbiology and Biotechnology},
year = {2025},
doi = {10.4014/jmb.2501.01024}
}
EUVIMED